INS and type 2 diabetes mellitus: Production of intestinal incretins, proteins released after food intake and which stimulate insulin secretion (Nauck and Meier, 2018), such as GLP (glucagon-like peptide) is reduced in patients with T2D (Mannucci et al., 2000).